Cite
HARVARD Citation
Hassanein, M. et al. (n.d.). Secondary AML patients with poor risk cytogenetics have a high risk of death post allogeneic stem cell transplantation in absence of chronic GVHD. Leukemia research. pp. S22-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hassanein, M. et al. (n.d.). Secondary AML patients with poor risk cytogenetics have a high risk of death post allogeneic stem cell transplantation in absence of chronic GVHD. Leukemia research. pp. S22-. [Online].